Lewy Body Disease

Original Editor - Henry Tan, Kevin Lam, Alex Mong, Andrew To as part of the Queen's University Neuromotor Function Project

Top Contributors - Henry Tan, Andrew To, Alex Mong, Lucinda hampton, Kim Jackson, Kevin Lam, Vidya Acharya, Claire Knott, 127.0.0.1, Evan Thomas and Lauren Lopez  

Introduction

LBD: more common in the elderly

Lewy body disease or Lewy body dementia (LBD), is a neurodegenerative disease (specifically a synucleinopathy) related to Parkinson disease.

Lewy body disease or Lewy body dementia (LBD) has been found to be strongly linked to a protein called alpha-synuclein. Abnormal accumulation of this protein in certain regions of the brain causes dramatic cognitive and motor deficits affecting behaviour, mood, movement, and thinking. LBD is one of the most common causes of dementia along with Alzheimers disease (AD). It is also classified as a parkinsonism plus syndrome.

Types of LBD

Dementia

There are 2 types of LBD generally described in the literature:

1. Dementia with Lewy Bodies: dementia occurring first or within one year of movement disorder.
2. Parkinson Disease Dementia: dementia occurring in a patient who receives a diagnosed of Parkinson's disease and then develops dementia symptoms after one year or more of the diagnosis.

People with either type generally develop similar symptoms as the disease progresses. Distinct Parkinsonian symptoms such as slowness of movement, rigidity, REM sleep behaviour disorder and visual hallucinations can help to distinguish DLB from Alzheimer’s disease.

Epidemiology

LBD occurs in older patients (onset typically in 50-70 years of age), and is sporadic. It is the second most common neurodegenerative cause of dementia in older patients (after AD), accounting for 15-20% of cases.

Etiology

The etiology of LBD is unknown. Genetics, environmental factors, and changes linked to aging, may have a role and research is still ongoing.

Clinical Presentation

The clinical features of LBD are the consequence of the blockage of information transfer from the striatum to the cortex, more notably the frontal lobe.

Signs and symptoms include:

• Recurrent visual hallucinations
• Visuospatial impairment (Stroop test, Clockface test)
• Executive function deficits (Nelson Card sort test)
• Parkinsonian motor features (mild gait impairments, resting tremor)
• Early extrapyramidal features (dystonia, akathisia, muscle rigidity, bradykinesia, tremor, tardive dyskinesia
• Fluctuating cognitive impairment (periods of coherence and alertness alternating with sequences of confusion and unresponsiveness)
• Attentional deficits
• Poor postural stability
• Neuroleptic sensitivity
• Orthostatic hypotension
  

Pathophysiology

The characteristic feature of dementia with Lewy bodies is the accumulation of Lewy bodies throughout the brain. These intracellular inclusions result from the aggregation of misfolded α-synuclein. Neurofibrillary tangles are also present, however they lack an amyloid core, as seen in AD.

Regions of the brain affected by LBD include: cerebral cortex, limbic cortex, hippocampus, midbrain, brainstem.

Source (http://labiotech.eu/major-cns-disease-milestones-in-biotech-2015/)

Diagnostic Procedures

It is important to realise that there is a significant overlap between many neurodegenerative diseases, and that a clear-cut distinction between entities is not always possible. No precise test can accurately diagnose LBD. A thorough assessment is useful to reach an alternative working diagnosis (or rules out similar conditions):

• Detailed history and examination
• Assessment of cognitive function
• Blood tests (e.g., vitamin B12 levels, chemistry panel, thyroid profile, syphilis, HIV) to rule out other causes of dementia

• Imaging studies (e.g., CT scan, MRI scan, SPECT scan, PET scan)
• Cerebrospinal fluid examinations have no significant role when conducted in these patients
• Sleep evaluation for REM sleep behavior disorder

Management

There is no effective treatment for LBD and the condition is progressive. The available pharmacological agents are only used to treat behavioral symptoms.

• Home care nurses play a crucial role in regularly assessing the patient and providing support services.
• Education of the caregiver is essential, the loved ones needing to be aware of the behavior changes, hallucinations, and fluctuations in cognition. Caregivers have to monitor the patient closely as they have a love level of functioning, with most unable to perform ADLs and are prone to falls and aspiration pneumonia.
• The pharmacist needs to educate caregivers that no medical therapy cures the cognitive changes and the drugs simply manage behavior and motor deficits ( and many have adverse effects).
• A mental health nurse is often needed as depression is common. Close communication between members of the interprofessional team is vital to improve outcomes.

Physiotherapy Management

Balance training

Physiotherapy for Lewy Body Disease is similar to that of Parkinson’s Disease. It can help manage parkinsonism that is prevalent in LBD by providing intervention such as strengthening and flexibility exercises and gait training. Aerobic exercise should be included to optimise cardiovascular fitness. Physiotherapy is especially helpful in improving balance and postural stability to minimize the risk of falls. With the addition of exercise, non-motor symptoms such as cognition, sleep and fatigue will improve. As the disease progresses and the dementia increases, exercise can be hard to do. Therefore, it is important to incorporate exercise in the early and middle stages of Lewy Body Disease. A study suggests that a high-intensity functional exercise program has positive outcomes on balance in these patients.

Tips to help make exercise easier to maintain:

• Provide visual cues by demonstrating exercises
• Play upbeat music or music the person enjoys
• Arrange exercise classes or include the support/care-person
• Do exercises in sitting
• Make exercise fun and enjoyable